Obesity Therapeutic Drugs Market Report

Europe Obesity Therapeutic Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 20, 2019
  • PAGES：168
  • REPORT CODE：GMM335328
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Obesity Therapeutic Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Obesity Therapeutic Drugs Market Segmentations:

    By Player:

    • Orexigen Therapeutics

    • Eisai

    • Novo Nordisk

    • GlaxoSmithKline

    • Norgine

    • Roche

    • Sanofi

    • Arena Pharmaceuticals

    • Vivus

    • Takeda Pharmaceutical

    • Shionogi

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Obesity Therapeutic Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Obesity Therapeutic Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Obesity Therapeutic Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Obesity Therapeutic Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Obesity Therapeutic Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Obesity Therapeutic Drugs for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Obesity Therapeutic Drugs for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Obesity Therapeutic Drugs for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Obesity Therapeutic Drugs Production Analysis by Top Regions

    • 5.2 Europe Obesity Therapeutic Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Obesity Therapeutic Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Obesity Therapeutic Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Obesity Therapeutic Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Obesity Therapeutic Drugs Landscape Analysis

    • 7.1 Germany Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 7.2 Germany Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    8. UK Obesity Therapeutic Drugs Landscape Analysis

    • 8.1 UK Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 8.2 UK Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    9. France Obesity Therapeutic Drugs Landscape Analysis

    • 9.1 France Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 9.2 France Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    10. Italy Obesity Therapeutic Drugs Landscape Analysis

    • 10.1 Italy Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 10.2 Italy Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    11. Spain Obesity Therapeutic Drugs Landscape Analysis

    • 11.1 Spain Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 11.2 Spain Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    12. Poland Obesity Therapeutic Drugs Landscape Analysis

    • 12.1 Poland Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 12.2 Poland Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    13. Russia Obesity Therapeutic Drugs Landscape Analysis

    • 13.1 Russia Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 13.2 Russia Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    14. Switzerland Obesity Therapeutic Drugs Landscape Analysis

    • 14.1 Switzerland Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    15. Turkey Obesity Therapeutic Drugs Landscape Analysis

    • 15.1 Turkey Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Obesity Therapeutic Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Obesity Therapeutic Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Obesity Therapeutic Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Obesity Therapeutic Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Orexigen Therapeutics

      • 19.1.1 Orexigen Therapeutics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Eisai

      • 19.2.1 Eisai Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Novo Nordisk

      • 19.3.1 Novo Nordisk Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GlaxoSmithKline

      • 19.4.1 GlaxoSmithKline Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Norgine

      • 19.5.1 Norgine Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Roche

      • 19.6.1 Roche Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sanofi

      • 19.7.1 Sanofi Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Arena Pharmaceuticals

      • 19.8.1 Arena Pharmaceuticals Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Vivus

      • 19.9.1 Vivus Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Takeda Pharmaceutical

      • 19.10.1 Takeda Pharmaceutical Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Shionogi

      • 19.11.1 Shionogi Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    The List of Tables and Figures (Totals 76 Figures and 115 Tables)

    • Figure Product Picture

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Obesity Therapeutic Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Obesity Therapeutic Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Obesity Therapeutic Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Obesity Therapeutic Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Obesity Therapeutic Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Obesity Therapeutic Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Obesity Therapeutic Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Obesity Therapeutic Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Obesity Therapeutic Drugs Production by Major Regions

    • Table Europe Obesity Therapeutic Drugs Production Share by Major Regions

    • Figure Europe Obesity Therapeutic Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Obesity Therapeutic Drugs Consumption by Major Regions

    • Table Europe Obesity Therapeutic Drugs Consumption Share by Major Regions

    • Table Germany Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table UK Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table France Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Obesity Therapeutic Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Germany Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table UK Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table France Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table France Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table France Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Italy Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Spain Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Poland Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Russia Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Obesity Therapeutic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Obesity Therapeutic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Obesity Therapeutic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Obesity Therapeutic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Orexigen Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexigen Therapeutics

    • Figure Sales and Growth Rate Analysis of Orexigen Therapeutics

    • Figure Revenue and Market Share Analysis of Orexigen Therapeutics

    • Table Product and Service Introduction of Orexigen Therapeutics

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Norgine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine

    • Figure Sales and Growth Rate Analysis of Norgine

    • Figure Revenue and Market Share Analysis of Norgine

    • Table Product and Service Introduction of Norgine

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Arena Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Arena Pharmaceuticals

    • Table Product and Service Introduction of Arena Pharmaceuticals

    • Table Company Profile and Development Status of Vivus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus

    • Figure Sales and Growth Rate Analysis of Vivus

    • Figure Revenue and Market Share Analysis of Vivus

    • Table Product and Service Introduction of Vivus

    • Table Company Profile and Development Status of Takeda Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical

    • Table Product and Service Introduction of Takeda Pharmaceutical

    • Table Company Profile and Development Status of Shionogi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi

    • Figure Sales and Growth Rate Analysis of Shionogi

    • Figure Revenue and Market Share Analysis of Shionogi

    • Table Product and Service Introduction of Shionogi

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US